U.S. pharma huge copyright scrapped two experimental weight loss drugs last yr—a at the time-day by day pill, lotiglipron, as a consequence of elevated liver enzymes as well as a twice-day by day pill, danuglipron, as a result of solid Negative effects—but CEO Albert Bourla has claimed the company is set to “Participate in and gain” while i